The global cocaine intoxication treatment market size was valued at USD 16.73 billion in 2025 and is projected to grow from USD 17.75 billion in 2026 to USD 28.55 billion by 2034, registering a CAGR of 6.12% during the forecast period (2026-2034). North America dominated the cocaine intoxication treatment market with a share of 43.17% in 2025.
Cocaine intoxication treatment involves emergency medical interventions used to manage the acute effects of cocaine on the cardiovascular, neurological, and other body systems. Cocaine intoxication treatments are commonly classified under HSN Code 3004 (medicaments for therapeutic or prophylactic uses, put up in measured doses or retail packaging) and SIC Code 2834 (Pharmaceutical Preparations).
The cocaine intoxication treatment market demand is driven by the need for rapid management of seizures and severe agitation. Emergency care providers use benzodiazepines for fluid therapy and temperature management, contributing to cocaine intoxication treatment market growth.
Download a Free Sample To learn more about this report,
Shift toward Precision Management of Cocaine-Induced Arrhythmias
The cocaine intoxication treatment market analysis shows a shift toward targeted management of cocaine-induced arrhythmias to address abnormal heart rhythms and reduce the risk of serious cardiovascular complications. Treatment approaches focus on cardiac monitoring, electrolyte correction, and appropriate medication based on the patient's condition. This trend is supporting more tailored emergency care for patients experiencing cocaine-related cardiac toxicity.
Development of Treatment Approaches for Cocaine Induced Rhabdomyolysis
Research into the cocaine intoxication treatment market is increasingly focused on managing cocaine-induced rhabdomyolysis, a condition involving muscle breakdown that can lead to acute kidney injury. Treatment typically involves intravenous fluids, electrolyte monitoring, and assessment of kidney function to manage complications.
Supply chain disruptions are expected to have a moderate impact on the cocaine intoxication treatment market share due to dependence on emergency medicines, benzodiazepines, and cardiovascular drugs. The market is expected to follow a stair-step recovery, as shortages of essential medicines, manufacturing delays, and disruptions in pharmaceutical distribution can affect treatment availability. The market is expected to grow at a CAGR of 6.12%, but supply chain constraints could lower this by 0.8 percentage points, resulting in a growth of around 5.32%. As supply conditions normalize, the cocaine intoxication treatment market growth is expected to gradually return to 6.12%.
The cocaine intoxication treatment market forecasts strategic investment activity driven by the development of novel pharmacological and device-based interventions and advancement in neuromodulation technologies. In September 2026, the National Institute on Drug Abuse awarded USD 692,449 to the University of Pennsylvania to study transcranial focused ultrasound as a potential device based treatment for cocaine use disorder, evaluating its safety and early efficacy.
Demand for Emergency Toxicology Services and Emphasis on Early Recognition of Sympathomimetic Toxicity Drive MarketDemand for emergency toxicology services is driving the cocaine intoxication treatment market as hospitals and emergency departments require rapid assessment and management of acute drug-related complications. The need to manage cocaine-associated chest pain, seizures, severe agitation, hyperthermia, and cardiac arrhythmias supports the use of emergency monitoring, toxicology expertise, and supportive treatment protocols.
Emphasis on early recognition of sympathomimetic toxicity is driving the cocaine intoxication treatment market as healthcare professionals seek to identify dangerous stimulant-related symptoms before they progress to life-threatening complications. US Centers for Disease Control and Prevention highlights the importance of recognizing stimulant overdose symptoms to improve response times.
Stigma Associated with Substance Use Disorders and Issues in Preventing Recurrent Cocaine Use Restrain Market Expansion
Stigma associated with substance use disorders can discourage individuals from seeking timely treatment for cocaine intoxication. Fear of judgment, social discrimination, or concerns about confidentiality may prevent patients from disclosing drug use or accessing emergency and follow-up care.Challenges in preventing recurrent cocaine use can increase the need for repeated emergency treatment and long-term support. Cocaine use disorder may involve psychological dependence, cravings, and underlying mental health conditions that require ongoing care.
Expansion of Emergency Toxicology Services and Structured Follow-Up Services for Patients Recovering from Cocaine Intoxication Offers Growth Opportunities
Hospitals, emergency care providers, and poison control centers can strengthen their capacity to assess and manage patients experiencing cocaine intoxication. These services require toxicology testing, clinical assessment, and coordinated treatment for complications associated with acute exposure. Revenue can be generated through toxicology laboratory services, emergency treatment contracts, specialized clinical support, and hospital procurement of relevant medical supplies.
Addiction treatment centers, behavioral health providers, and outpatient clinics can offer follow-up services for patients who need support after an episode of cocaine intoxication. These services can include substance use assessments, behavioral counseling, relapse prevention planning, and referrals to appropriate treatment programs.
Benzodiazepines led the drug class segment, accounting for a share of 38.4% in 2025, reflecting their established role in managing cocaine-induced agitation, seizures, and excessive sympathetic activity. Their use under clinical supervision can help stabilize patients and reduce the risk of complications associated with acute intoxication.
The central nervous system (CNS) modulators and investigational agents segment is projected to register a CAGR of 7.48% during the forecast period, driven by research into alternative treatment approaches for cocaine-related neurological and cardiovascular effects.
Request Customizationto receive a tailored report.
Intravenous dominated the route of administration segment with a share of 46.3% in 2025. This dominance is supported by the need for rapid medication delivery and close clinical monitoring. Intravenous administration allows healthcare professionals to adjust treatment promptly according to a patient's symptoms and clinical response.
The inhalation segment is estimated to record a CAGR of 6.89% during the forecast period, reflecting interest in rapidly delivered medications for selected acute care applications.
In 2025, hospital pharmacies accounted for a share of 61.8% in 2025, owing to the need for immediate access to medications used in emergency departments and inpatient settings. Hospitals maintain supplies of emergency medicines to support supervised treatment of seizures, agitation, and cardiovascular complications.
The online pharmacies segment is anticipated to register a CAGR of 7.21% during the forecast period, driven by the broader adoption of digital pharmacy services and online medication ordering.
Speak to an Analystto discuss market opportunities.
The North America cocaine intoxication treatment market accounted for a dominant share of 43.17% in 2025.
The American Heart Association’s poisoning management guidelines provide clinical recommendations for life-threatening cocaine toxicity, including the management of severe hyperthermia and cocaine-induced arrhythmias. These protocols support the use of evidence-based arrhythmia management and toxicology practices in US emergency departments.
Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) collects emergency department data on injuries and poisoning-related incidents, supporting the identification of patterns in substance-related emergencies. This surveillance activities highlight the need for timely assessment and treatment of cocaine intoxication, creating demand for emergency toxicology services, cardiac monitoring equipment,
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific cocaine intoxication treatment market is projected to grow at a CAGR of 7.98% during the forecast period, making it the fastest-growing region.
India’s National Poisons Information Centre (NPIC) at AIIMS, New Delhi, provides round the clock toxicology guidance to healthcare professionals and emergency services for poisoning diagnosis and management. This service supports emergency response capabilities relevant to cocaine toxicity and other cases of acute stimulant poisoning.
Drug Situation Report, released by the National Narcotics Control Commission, documented changes in drug-related cases and the emergence of new addictive substances. These developments highlight the importance given to toxicology assessment and emergency care for substance-related complications in the Chinese healthcare ecosystem.
Tokyo Metropolitan Bokutoh Hospital provides emergency medical services for patients with acute and life-threatening conditions. These services require rapid toxicology assessment and continuous monitoring of cardiovascular and neurological complications, creating demand for emergency toxicology testing, cardiac monitoring equipment, and supportive treatments for patients experiencing severe stimulant intoxication.
The Europe cocaine intoxication treatment market is likely to achieve a growth rate of 5.63% during the forecast period.
NHS provides access to specialist cocaine addiction treatment through local drug treatment services, including cognitive behavioral therapy and support for related symptoms. These services strengthen the role of addiction medicine and ongoing supportive care for people affected by cocaine use.
The Department of Clinical Toxicology at TUM University Hospital rechts der Isar in Munich, which participates in the European Drug Emergencies Network (Euro-DEN Plus) and provides specialized care for patients with acute drug toxicity. Its clinical toxicology services include the assessment and management of stimulant-related emergencies, highlighting the need for cardiovascular monitoring and toxicology testing.
The Latin America cocaine intoxication treatment market will expand to 6.68% CAGR during the forecast period. Sistema Único de Saúde (SUS) provides mental health and substance use care through its Psychosocial Care Centers (CAPS) in Brazill.
The Mexican Social Security Institute (IMSS) also advises patients with suspected cocaine intoxication to seek emergency care for symptoms such as chest pain, extreme agitation, and loss of consciousness.
The cocaine intoxication treatment market competitive landscape is highly fragmented, with established pharmaceutical manufacturers, generic drug producers, and specialized providers. Key players such as Indivior, Pfizer, Hikma Pharmaceuticals, Viatris, and Teva Pharmaceuticals are estimated to account for 20–25% of the global cocaine intoxication treatment market share.
Established players compete mainly through the availability of emergency medicines, seizure control therapies, and hospital supply capabilities. Emerging and regional players in the cocaine intoxication treatment market ecosystem focus on cost-effective generic medicines, and specialized treatment solutions.
August 2026: Solvonis Therapeutics announced that its investigational candidate SVN-015 advanced to further evaluation under the U.S. National Institute on Drug Abuse’s Addiction Treatment Discovery Program following encouraging initial laboratory screening.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Bone Metastasis Market Size, Share, Growth, Analysis, Report, 2034
Ibuprofen Market Size, Share, Growth, Analysis, Report, 2034
Congenital Hyperinsulinism Treatment Market Size, Opportunities, 2034
Acute Kidney Injury Treatment Market Size, Forecast, Demand, 2034
Clinical Trial Packaging Market Size, Forecast, Demand, 2034
Cryptococcosis Market Size, Forecast, Demand, Opportunities, 2034
We are featured on:
sales@straitsresearch.com